These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 1831135)

  • 1. Potassium channel opening properties of a novel compound, NIP-121, cromakalim and nicorandil in rat aorta and portal vein.
    Masuda Y; Arakawa C; Yamashita T; Miyajima M; Shigenobu K; Kasuya Y; Tanaka S
    Eur J Pharmacol; 1991 Apr; 195(3):323-31. PubMed ID: 1831135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium channel openers relax A23187-induced nifedipine-resistant contraction of rat aorta.
    Yamashita T; Masuda Y; Tanaka S
    J Cardiovasc Pharmacol; 1994 Dec; 24(6):914-20. PubMed ID: 7898074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery.
    Fujiwara T; Angus JA
    Br J Pharmacol; 1996 Dec; 119(8):1549-56. PubMed ID: 8982500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels.
    Weir SW; Weston AH
    Br J Pharmacol; 1986 May; 88(1):121-8. PubMed ID: 2423172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of nicorandil by 86Rb efflux and isometric vasorelaxation studies in vascular smooth muscle.
    Kreye VA; Lenz T; Pfründer D; Theiss U
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S8-12. PubMed ID: 1282181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potassium channel-opening and vasorelaxant profiles of a novel compound YM099 in rat isolated portal vein and rabbit isolated aorta.
    Uchida W; Hirano Y; Shirai Y; Taguchi T; Masuda N; Shibasaki K; Hirano S; Matsumoto Y; Tsuzuki R; Yanagisawa I
    Arch Int Pharmacodyn Ther; 1994; 327(3):330-43. PubMed ID: 7848015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dualistic mode of action of the vasodilator drug, nicorandil, differentiated by glibenclamide in 86Rb flux studies in rabbit isolated vascular smooth muscle.
    Kreye VA; Lenz T; Theiss U
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):70-5. PubMed ID: 1827659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rubidium on responses to potassium channel openers in rat isolated aorta.
    Greenwood IA; Weston AH
    Br J Pharmacol; 1993 Aug; 109(4):925-32. PubMed ID: 8401946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery.
    Eltze M
    Eur J Pharmacol; 1989 Jun; 165(2-3):231-9. PubMed ID: 2528466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissimilarity in the mechanisms of action of KRN2391, nicorandil and cromakalim in canine renal artery.
    Kasai H; Fukata Y; Harada K; Fukushima H; Ogawa N
    J Pharm Pharmacol; 1993 Mar; 45(3):222-4. PubMed ID: 8097782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil.
    Yanagisawa T; Teshigawara T; Taira N
    Br J Pharmacol; 1990 Sep; 101(1):157-65. PubMed ID: 2149290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The action of diazoxide and minoxidil sulphate on rat blood vessels: a comparison with cromakalim.
    Newgreen DT; Bray KM; McHarg AD; Weston AH; Duty S; Brown BS; Kay PB; Edwards G; Longmore J; Southerton JS
    Br J Pharmacol; 1990 Jul; 100(3):605-13. PubMed ID: 2167738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of imidazoline-related compounds on the mechanical response to nicorandil in the rat portal vein.
    Okumura K; Ichihara K; Nagasaka M
    Eur J Pharmacol; 1992 May; 215(2-3):253-7. PubMed ID: 1396988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of cromakalim-, pinacidil-, and nicorandil-induced relaxation of the 5-hydroxytryptamine precontracted rat isolated basilar artery.
    Ksoll E; Parsons AA; Mackert JR; Schilling L; Wahl M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):377-83. PubMed ID: 1830131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicorandil as a nitrate, and cromakalim as a potassium channel opener, dilate isolated porcine large coronary arteries in an agonist-nonselective manner.
    Satoh K; Mori T; Yamada H; Taira N
    Cardiovasc Drugs Ther; 1993 Aug; 7(4):691-9. PubMed ID: 8241013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the in vitro effects of K+ channel modulators on detrusor and portal vein strips from guinea pigs.
    Zografos P; Li JH; Kau ST
    Pharmacology; 1992; 45(4):216-30. PubMed ID: 1438528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil.
    Wilson C; Coldwell MC; Howlett DR; Cooper SM; Hamilton TC
    Eur J Pharmacol; 1988 Aug; 152(3):331-9. PubMed ID: 2851450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K+ channel-opening properties of a novel compound, NIP-121, in guinea pig myocardium as compared with those of cromakalim.
    Matsuda T; Okazaki K; Kato Y; Tanaka H; Shigenobu K
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):608-13. PubMed ID: 8569223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potassium channel openers, NIP-121 and cromakalim, enhance the relaxation induced by sodium nitroprusside in the guinea-pig isolated trachea.
    Shikada K; Tanaka S
    Br J Pharmacol; 1992 Dec; 107(4):1116-20. PubMed ID: 1334750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K+ channel opening mediates the vasorelaxant effects of nicorandil in the intact vascular system.
    Cavero I; Pratz J; Mondot S
    Z Kardiol; 1991; 80 Suppl 7():35-41. PubMed ID: 1838848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.